ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,571Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 1844

$1.36M Total Retail Price of All Prescriptions

Rank: 19 out of 1844

656 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 656 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 656 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 14,908 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 686 596 1 1
OMEPRAZOLE 575 479 2 5
AMLODIPINE BESYLATE 505 479 3 6
WARFARIN SODIUM 502 499 4 13
FUROSEMIDE 465 424 5 7
DONEPEZIL HCL 458 443 6 26
HYDROCODONE-ACETAMINOPHEN 426 314 S3 7 2
NAMENDA 401 401 8 33
LISINOPRIL 384 305 9 4
METOPROLOL SUCCINATE 382 313 10 14
SIMVASTATIN 322 278 11 3
POTASSIUM CHLORIDE 308 303 12 16
CARVEDILOL 240 233 13 22
GABAPENTIN 236 206 14 15
CITALOPRAM HBR 223 194 15 19
DIOVAN 212 206 16 58
TRAMADOL HCL 209 183 17 18
PRAVASTATIN SODIUM 208 182 18 10
METOPROLOL TARTRATE 206 195 19 11
ZOLPIDEM TARTRATE 187 132 20 23
PANTOPRAZOLE SODIUM 185 169 21 32
PREDNISONE 183 156 22 40
JANUVIA 182 145 23 77
HYDROCHLOROTHIAZIDE 179 170 24 9
ALENDRONATE SODIUM 175 173 25 25
MIRTAZAPINE 171 155 26 49
SERTRALINE HCL 168 157 27 21
CRESTOR 165 109 28 30
ATORVASTATIN CALCIUM 164 132 29 12
ESCITALOPRAM OXALATE 161 128 30 52
LOSARTAN POTASSIUM 142 128 31 24
CYMBALTA 139 104 32 36
ATENOLOL 133 121 33 17
DIGOXIN 126 124 34 67
CLOPIDOGREL 122 120 35 34
LANTUS 121 113 36 42
PLAVIX 117 106 37 61
POLYETHYLENE GLYCOL 3350 112 99 38 39
SYNTHROID 111 83 39 55
METFORMIN HCL ER 105 95 40 46
NEXIUM 103 49 41 31
RISPERIDONE 99 75 42 65
LANTUS SOLOSTAR 93 56 43 97
SPIRONOLACTONE 92 90 44 60
GLIMEPIRIDE 90 77 45 35
ISOSORBIDE MONONITRATE ER 88 88 46 59
AZITHROMYCIN 88 72 46 37
AMLODIPINE BESYLATE-BENAZEPRIL 88 67 46 80
ALLOPURINOL 87 82 49 29
NOVOLOG 84 84 50 84
CYCLOBENZAPRINE HCL 83 38 R 51 53
MELOXICAM 80 54 52 28
METFORMIN HCL 79 47 53 8
KLOR-CON M20 77 50 54 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 66 55 20
ADVAIR DISKUS 74 62 56 51
FAMOTIDINE 73 60 57 63
LEVOFLOXACIN 73 70 57 78
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 66 59 73
TAMSULOSIN HCL 70 70 60 27
HUMALOG 70 50 60 114
OXYBUTYNIN CHLORIDE ER 69 55 62 126
SPIRIVA 67 56 63 57
BUMETANIDE 67 50 63 121
LOSARTAN-HYDROCHLOROTHIAZIDE 62 48 65 47
DIVALPROEX SODIUM 60 44 66 74
FLUTICASONE PROPIONATE 58 44 67 50
TRIAMTERENE-HCTZ 57 56 68 48
ESTRADIOL 57 36 R 68 181
SINGULAIR 57 29 68 102
LANSOPRAZOLE 57 51 68 194
ACTOS 55 45 72 130
ZETIA 54 40 73 81
LIDODERM 54 35 73 155
NYSTOP 54 52 73 185
BENAZEPRIL HCL 53 50 76 75
ACTONEL 53 53 76 238
DIOVAN HCT 53 39 76 96
EXELON 53 53 76 112
CEPHALEXIN 52 49 80 56
ATELVIA 52 52 80 278
PRENATABS RX 51 51 82 232
DEXILANT 51 36 82 228
LEXAPRO 50 45 84 179
TRAZODONE HCL 50 30 84 43
PAROXETINE HCL 50 29 84 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.